Sarepta Therapeutics (SRPT) Depreciation & Amortization (CF) (2010 - 2026)
Sarepta Therapeutics' quarterly Depreciation & Amortization (CF) came in at $10.6 million in Q1 2026, up 6.17% year-on-year from $10.0 million in Q1 2025, and up 101.68% quarter-over-quarter from $5.3 million in Q4 2025.
Sarepta Therapeutics has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $10.6 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 6.17% year-over-year to $10.6 million; the trailing twelve-month figure through Mar 2026 stood at $45.1 million (up 15.86% YoY), and the FY2025 full-year result was $44.5 million, up 18.02% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $10.6 million, up from $5.3 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $18.4 million in Q3 2025, with the low at $5.3 million in Q4 2025.
- Average Depreciation & Amortization (CF) over 5 years is $10.5 million, with a median of $10.6 million recorded in 2026.
- Peak annual rise in Depreciation & Amortization (CF) reached 88.15% in 2025, while the deepest fall reached 49.76% in 2025.
- Tracing SRPT's Depreciation & Amortization (CF) over 5 years: stood at $10.6 million in 2022, then advanced by 7.76% to $11.4 million in 2023, then retreated by 8.06% to $10.5 million in 2024, then sank by 49.76% to $5.3 million in 2025, then soared by 101.68% to $10.6 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $10.6 million (Q1 2026), $5.3 million (Q4 2025), and $18.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 10.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.59 Mn |
| Mar 31, 2026 | 10.59 Mn |
| Dec 31, 2025 | 5.25 Mn |
| Dec 31, 2025 | 5.25 Mn |
| Sep 30, 2025 | 18.45 Mn |
| Sep 30, 2025 | 18.45 Mn |
| Jun 30, 2025 | 10.84 Mn |
| Jun 30, 2025 | 10.84 Mn |
| Mar 31, 2025 | 9.98 Mn |
| Mar 31, 2025 | 9.98 Mn |
| Dec 31, 2024 | 10.46 Mn |
| Dec 31, 2024 | 10.46 Mn |
| Sep 30, 2024 | 9.81 Mn |
| Sep 30, 2024 | 9.81 Mn |
| Jun 30, 2024 | 8.72 Mn |
| Jun 30, 2024 | 8.72 Mn |
| Mar 31, 2024 | 8.74 Mn |
| Mar 31, 2024 | 8.74 Mn |
| Dec 31, 2023 | 11.37 Mn |
| Dec 31, 2023 | 11.37 Mn |
| Sep 30, 2023 | 10.93 Mn |
| Sep 30, 2023 | 10.93 Mn |
| Jun 30, 2023 | 10.79 Mn |
| Jun 30, 2023 | 10.79 Mn |
| Mar 31, 2023 | 11.31 Mn |
| Mar 31, 2023 | 11.31 Mn |
| Dec 31, 2022 | 10.55 Mn |
| Dec 31, 2022 | 10.55 Mn |
| Sep 30, 2022 | 10.70 Mn |
| Sep 30, 2022 | 10.70 Mn |
| Jun 30, 2022 | 9.89 Mn |
| Jun 30, 2022 | 9.89 Mn |
| Mar 31, 2022 | 10.72 Mn |
| Mar 31, 2022 | 10.72 Mn |
| Dec 31, 2021 | 10.15 Mn |
| Dec 31, 2021 | 10.15 Mn |
| Sep 30, 2021 | 10.50 Mn |
| Sep 30, 2021 | 10.50 Mn |
| Jun 30, 2021 | 8.45 Mn |
| Jun 30, 2021 | 8.45 Mn |
| Mar 31, 2021 | 8.93 Mn |
| Mar 31, 2021 | 8.93 Mn |
| Dec 31, 2020 | 7.29 Mn |
| Dec 31, 2020 | 7.29 Mn |
| Sep 30, 2020 | 6.62 Mn |
| Sep 30, 2020 | 6.62 Mn |
| Jun 30, 2020 | 6.48 Mn |
| Jun 30, 2020 | 6.48 Mn |
| Mar 31, 2020 | 6.53 Mn |
| Mar 31, 2020 | 6.53 Mn |
| Dec 31, 2019 | 6.65 Mn |
| Dec 31, 2019 | 6.65 Mn |
| Sep 30, 2019 | 6.74 Mn |
| Sep 30, 2019 | 6.74 Mn |
| Jun 30, 2019 | 6.23 Mn |
| Jun 30, 2019 | 6.23 Mn |
| Mar 31, 2019 | 4.88 Mn |
| Mar 31, 2019 | 4.88 Mn |
| Dec 31, 2018 | 3.53 Mn |
| Dec 31, 2018 | 3.53 Mn |
| Sep 30, 2018 | 3.59 Mn |
| Sep 30, 2018 | 3.59 Mn |
| Jun 30, 2018 | 2.87 Mn |
| Jun 30, 2018 | 2.87 Mn |
| Mar 31, 2018 | 2.25 Mn |
| Mar 31, 2018 | 2.25 Mn |
| Dec 31, 2017 | 2.12 Mn |
| Dec 31, 2017 | 2.12 Mn |
| Sep 30, 2017 | 2.56 Mn |
| Sep 30, 2017 | 2.56 Mn |
| Jun 30, 2017 | 1.77 Mn |
| Jun 30, 2017 | 1.77 Mn |
| Mar 31, 2017 | 1.64 Mn |
| Mar 31, 2017 | 1.64 Mn |
| Dec 31, 2016 | 1.66 Mn |
| Dec 31, 2016 | 1.66 Mn |
| Sep 30, 2016 | 1.07 Mn |
| Sep 30, 2016 | 1.07 Mn |
| Jun 30, 2016 | 1.48 Mn |
| Jun 30, 2016 | 1.48 Mn |
| Mar 31, 2016 | 1.40 Mn |
| Mar 31, 2016 | 1.40 Mn |
| Dec 31, 2015 | 1.36 Mn |
| Dec 31, 2015 | 1.36 Mn |
| Sep 30, 2015 | 1.31 Mn |
| Sep 30, 2015 | 1.31 Mn |
| Jun 30, 2015 | 1.29 Mn |
| Jun 30, 2015 | 1.29 Mn |
| Mar 31, 2015 | 1.28 Mn |
| Mar 31, 2015 | 1.28 Mn |
| Dec 31, 2014 | 1.16 Mn |
| Dec 31, 2014 | 1.16 Mn |
| Sep 30, 2014 | 1.05 Mn |
| Sep 30, 2014 | 1.05 Mn |
| Jun 30, 2014 | 960,000.00 |
| Jun 30, 2014 | 960,000.00 |
| Mar 31, 2014 | 523,000.00 |
| Mar 31, 2014 | 523,000.00 |
| Dec 31, 2013 | 279,000.00 |
| Dec 31, 2013 | 279,000.00 |
| Sep 30, 2013 | 287,000.00 |
| Sep 30, 2013 | 287,000.00 |
| Jun 30, 2013 | 260,000.00 |
| Jun 30, 2013 | 260,000.00 |
| Mar 31, 2013 | 451,000.00 |
| Mar 31, 2013 | 451,000.00 |
| Dec 31, 2012 | 435,000.00 |
| Dec 31, 2012 | 435,000.00 |
| Sep 30, 2012 | 375,000.00 |
| Sep 30, 2012 | 375,000.00 |
| Jun 30, 2012 | 362,000.00 |
| Jun 30, 2012 | 362,000.00 |
| Mar 31, 2012 | 353,000.00 |
| Mar 31, 2012 | 353,000.00 |
| Dec 31, 2011 | 537,000.00 |
| Dec 31, 2011 | 537,000.00 |
| Sep 30, 2011 | 273,000.00 |
| Sep 30, 2011 | 273,000.00 |
| Jun 30, 2011 | 251,000.00 |
| Jun 30, 2011 | 251,000.00 |
| Mar 31, 2011 | 239,000.00 |
| Mar 31, 2011 | 239,000.00 |
| Dec 31, 2010 | 410,000.00 |
| Dec 31, 2010 | 410,000.00 |
| Sep 30, 2010 | 355,000.00 |
| Sep 30, 2010 | 355,000.00 |